Melatonin agonist treatment

Details Melatonin agonist treatment Melatonin agonist treatment

A - Human Necessities

61

K

A61K 31/343 (2006.01) A61P 25/20 (2006.01)

Patent

CA 2666293

This invention provides methods of administering (1 R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide as a melatonin receptor agonist to a human subject to treat or prevent a circadian rhythm disorder or sleep disorder.

L'invention porte sur un traitement consistant à administrer à l'homme à des doses efficaces l'agoniste du récepteur de la mélatonine (1 R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]méthyl]propanamide pour traiter ou prévenir les troubles du rythme circadien ou de sommeil.

Affiliated with

Also associated with

Rating

Melatonin agonist treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Melatonin agonist treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melatonin agonist treatment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1956014